HMOX1 and Other metabolic disease: The interlink between AMPK and Nrf2/HO-1 signalling and its potential in treatment of metabolic disease and cancer resurge in the new clinical perspective as a therapeutic option, particularly the cross-activation of these pathways that can control oxidative stress, inflammatory status, and cell metabolism, conferring protective actions against the progression of diseases and improving treatment responses42.